◀ Back to EGFR
EGFR — IGF2
Text-mined interactions from Literome
Knowlden et al., Endocrinology 2005
(Breast Neoplasms) :
IGF-II activated both IGF-IR and
EGFR in Tam-R cells, whereas only activation of IGF-IR was observed in wild-type cells ...
IGF-II promoted direct association of c-SRC with IGF-IR, phosphorylated c-SRC, and increased
EGFR phosphorylation at tyrosine 845, a c-SRC dependent phosphorylation site ... Similarly, in T47D-R cells, AG1024 and SU6656 inhibited basal and
IGF-II induced phosphorylation of c-SRC and
EGFR , and SU6656 reduced TGFalpha induced EGFR activity ... These results suggest the existence of a unidirectional
IGF-IR/EGFR cross-talk mechanism whereby
IGF-II , acting through the IGF-IR,
regulates basal and ligand activated EGFR signaling and cell proliferation in a c-SRC dependent manner in Tam-R cells
Morgillo et al., Clin Cancer Res 2007
(Carcinoma, Non-Small-Cell Lung...) :
Treatment with gefitinib, but not cetuximab,
induced EGFR : IGF-IR heterodimerization and activation of
IGF-IR and its downstream signaling mediators, resulting in increased survivin expression in NSCLC cell lines with high levels of IGF-IR expression
Song et al., Endocrinology 2007
(Breast Neoplasms) :
Using MCF-7 breast cancer cells, we for the first time demonstrated that a sequential activation of IGF-IR, MMP, and EGFR existed in E2 and IGF-I actions, which was supported by evidence that the selective inhibitors of
IGF-IR and MMP or knockdown of IGF-IR all
inhibited E2- or IGF-I induced
EGFR phosphorylation
Barnes et al., Clin Cancer Res 2007
(Head and Neck Neoplasms) :
Stimulation of head and neck cancer cells with either
IGF or EGF
resulted in IGF-IR and
EGFR heterodimerization, but only IGF caused activating phosphorylation of both receptors
Li et al., Am J Physiol Heart Circ Physiol 2010
(Disease Models, Animal...) :
In addition, the enhanced phosphorylation of
EGF-R in VSMC from SHR compared with WKY was also
attenuated by inhibitors of AT(1), ET ( A ), ET ( B ), and EGF-R but not by inhibitors of platelet derived growth factor receptor or
insulin-like growth factor receptor
Shaw et al., Br J Cancer 2011
(Adenoma...) :
We show here that, in murine intestinal adenomas acutely exposed to a small molecular inhibitor of EGFR ( gefitinib ), there is concurrent suppression of
EGFR downstream signalling and
induction of
IGF signalling